Galmed Pharmaceuticals
Why Robinhood?
You can watch GLMD and buy or sell other stocks, ETFs, and their options commission-free!About GLMD
Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus.
GLMD Key Statistics
Stock Snapshot
With a market cap of 108.53M, Galmed Pharmaceuticals(GLMD) trades at $4.31. The stock has a price-to-earnings ratio of -0.47.
Galmed Pharmaceuticals(GLMD) stock opened on 2026-10-12 at —. The price climbed to — and dipped to —.
The Galmed Pharmaceuticals(GLMD)'s current trading volume is 0, compared to an average daily volume of 1.18M.
During the past year, Galmed Pharmaceuticals(GLMD) stock moved between $0.29 at its lowest and $0.95 at its peak.
During the past year, Galmed Pharmaceuticals(GLMD) stock moved between $0.29 at its lowest and $0.95 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.